I know many of us (including myself) are skeptical about this company (they charge 50 thousand if you want to be a 'volunteer test subject'). I don't begrudge anyone an honest living. So let's just hope they come up with some good results to help us.
---------------------------------
"FGF-1, Zhittya Genesis Medical’s treatment candidate, appeared safe and effective at improving motor and cognitive function in the first Parkinson’s disease patients given the therapy in an early clinical trial and followed for six months."
"That’s according to a press release from the company that also announced a presentation of these follow-up data in a webinar, titled “Zhittya’s Parkinson’s Disease Research Study: 6-Month Patient Follow-Up Report,” that took place Dec. 20."
"While the release did not provide details on the number of participants or location of the small study, these findings seem to be in agreement with previous, preliminary trial findings."
as far as i know, for now, they are only testing overseas... but a quick skim of that article (towards the bottom, I think) said they have requested from the FDA "Compassionate Speed-up" for trials in the USA.
If you dig a bit deeper you will find that the "Team at Zhittya" is stacked with Husbands / Wifes / Sons, etc. Really shows professionalism?
The sons are still at University and they are holding key positions with no experience in the stated titles that they are accredited with.
A serious look at the talent pool at Zhittya, shows that they are maybe looking for investment money so the families on the team can all cash in.
Dan Montano - CEO
Viktoriya Montano - Vice President of Strategic Innovation
Ernest Montano - Exec. Vice President of Asia Pacific Region
Sergiy Montano - Vice President of Marketing
Daniel H. Montano - Vice President of Drug Development
Very weary of the set up.
A professional company looking to truly be successful employs people with dedicated skill sets that have built a reputation from their past business acumen to show that they are capable of delivering success.
Do you see this happening with the team at Zhittya?
I agree, this family set up looks a bit unusual, but at least they are exploring ways that differ from mainstream approach of treating PD.I have a feeling that Big Pharma sabotaged most of the PD research and is filtering the traffic via foundations like MJ.Fox.
i can tell you this much... BILLIONS on research were spent on HIV/AIDS ... it was all 'political' (IMHO) ... FACT: 25 BILLION a year is spent by the feds to 'manage/ treat' our disease but 'only' 250 million is spent on research
----------------------------------------
BOTTOM LINE: For every dollar of treatment ... the feds are spending 'one penny' on research ...
watched their presentation the other day. Two test persons with anecdotal evidence. Yes, some motor improvements but not uniform. They have no idea of optimum dose or duration. Testing in BVI right now and next in countries like Mexico which are lenient though they are trying to get US approval. Years till there’s a viable product if then. Big pitch In presentation to sponsors /partners and a lot of how much this is costing them. Disappointing on many fronts.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Cure Parkinson’s and Van Andel Institute announce funding for a phase 1 clinical trial of low-dose lithium in Parkinson’s disease
Trials coming from Zhittya 
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107,ERK inhibitor that selectively inhibits neuroinflammation
